Diagnostics & Precision Medicine
![](https://eu-admin.eventscloud.com/file_uploads/1c4bcf69e5e06828d7c69b394408db16_logo-fiftytwonorth2.png)
Developing affordable, patient-centred and fully-integrated clinical, AI and medical-device based systems. Its first product addresses neutropenic sepsis: the most fatal side-effect of chemotherapy.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/fe5cc929c21d23eb770684edc4bdec1f_profile-pic5.png)
Umaima Ahmad
CEO & Co-Founder
![](https://eu-admin.eventscloud.com/file_uploads/2b27e7967f07b1fc84c0ae2d0f91e653_Maskgroup14.png)
A technology company dedicated to unleashing the potential of genomics to transform human health by using their technology to remove the noise from genomic data.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/b8d73d97a5597280d4e609bae7ede445_profile-pic52.png)
Dr Barnaby Balmforth
Co-Founder & CEO
![](https://eu-admin.eventscloud.com/file_uploads/571779a85be848ca121c95813c02d2de_cancertain-logo.png)
CanCertain uses advanced 3D cell culture techniques to help both patients and oncologists find the optimal cancer treatment using their own cancer cells.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/f5fc4e04000aabfd7d02b2956973b992_profile-pic13.png)
Dharmesh Mehta
Business Development Director
![](https://eu-admin.eventscloud.com/file_uploads/06f0efe523e1d4a9315db23a53a31a14_Maskgroup15.png)
Glyconics is developing a range of Miniaturized InfraRed (IR) products for use at point-of-care to produce diagnostic data in minutes, focussing initially on diabetes screening.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/e41bed82e936caa7028f2a5e65d856b7_profile-pic33.png)
Dr Kam Pooni
CEO
![](https://eu-admin.eventscloud.com/file_uploads/6d0be2eae801f51af51eae934c11a5ed_logo-lateralDX.png)
Lateral Dx is a contract development company specialising in Lateral Flow Technology. They have developed a fast, quantitative antibody screening system that delivers a cost-effective method of screening antibodies for use in Lateral flow tests (LFT).
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/133536cfb7e4af56ef6ae36df5e22f50_no-photo.png)
Richard Campbell
Managing Director
![](https://eu-admin.eventscloud.com/file_uploads/8af2dba0406e1fa68256b29ff3a2ba38_mursla_logo_light11.png)
Novel multi-omics liquid biopsy tests via Extracellular Vesicles (EVs) enabling the real time analysis of tissue-specific bioactivity in blood. Its first product is a blood test for early detection of liver cancer among high-risk patients.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/b606423fd2081f4ccde89bc93810e431_profile-pic34.png)
Pierre Arsene
Founder & CEO
![](https://eu-admin.eventscloud.com/file_uploads/4cb5c3fd745e53283997c750a48d15b8_Oncimmune_Colour41.png)
Providing services to clients for the discovery of Antibody/ Autoantibody Biomarker Signatures.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/d0170901de7414c3e4143ab7367c5a68_profile-pic6.png)
Adam M Hill
CEO
![](https://eu-admin.eventscloud.com/file_uploads/280e2984036d7f71ceeb771d83bc6321_logo-surescreen1.png)
Manufacturing point of care medical diagnostics that give results at the patient side within minutes.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/640ade73baae86d57f337caa04a775ae_profile-pic51.png)
David Campbell
Director
![](https://eu-admin.eventscloud.com/file_uploads/d12390afe2029b0766e6dbb156e78970_logo-zilico.png)
Using proprietary bioimpedance technology to characterise cell changes during disease progression which provides a status of disease for clinicians.
Visit company site![](https://eu-admin.eventscloud.com/file_uploads/970e545c8104ed1398fbcbfb2c3e347e_profile-pic36.png)
Sameer Kothari
CEO
Category Winners
See our 2023 Category Winners
Meet our 6 Category Winners selected for being market leading
UK Innovators in life sciences.